Joint pain relief often begins with simple, steady care

A lighter task keeps the joint moving without as much strain

Reduce the distance, weight, speed, or time that brought on soreness. Keep an easier form of the same motion when it feels safe to you. A flat walk may replace a steep trail for a while. For your stiff shoulder, slowly lift the arm only as far as feels comfortable. Add a little more work after the soreness settles by the next day. Cut back again when swelling or soreness keeps growing.

One small change is easier to judge than stopping everything.

Heat, ice, and medicine must fit the person

Heat may loosen a stiff joint before movement. Ice may ease an ache after a busy day. Either one can harm skin, so put a cloth between it and your body. Drugstore medicine isn't harmless. Kidney, heart, or stomach trouble can change which drug is safe. So can medicine taken to thin the blood. Ask a doctor or pharmacist to check the label against your health and drug list.

Useful medicine should make sleep or safe movement easier.

Lasting soreness needs a new exam

Make an appointment when home care isn't bringing back normal use. Bring a list of painful motions and the steps that helped. The doctor will check the sore joint and nearby areas. The exam may lead to different exercises, safer medicine, an X-ray, or a surgery talk. It may also show that the ache begins somewhere else. Keep using easier motion while waiting, unless the joint becomes hot, red, badly swollen, or too weak to use.

Medical providers at QC Kinetix in Scottsdale offer regenerative treatments using blood, fat, or marrow prepared for the sore joint.

Sources

1. A Cochrane overview of 21 systematic reviews (381 studies, 37,143 participants) covering rheumatoid arthritis, osteoarthritis, fibromyalgia, low back pain, neck disorder and other chronic pain conditions concluded that physical activity and exercise are interventions with few adverse events that may improve pain severity and physical function - but that the quality of the evidence is low, effects on pain were inconsistent across reviews, and physical function improved significantly in 14 reviews with only small-to-moderate effect sizes. The commonest reported adverse event was increased muscle soreness that settled within weeks.

   Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH — Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.. Cochrane Database of Systematic Reviews, 2017. DOI: 10.1002/14651858.CD011279.pub3.

2. A 2025 Bayesian network and dose-response meta-analysis of 92 randomised trials in 6,079 people with knee or hip osteoarthritis found aerobic training most likely to rank first for pain relief (SUCRA 84.7%; SMD -1.00, 95% CrI -1.50 to -0.62), ahead of strength plus flexibility (SUCRA 73.0%), yoga (63.7%), strength alone (55.9%) and flexibility alone (39.8%) - but with NO statistically significant difference between exercise types. Pooled across modalities, the dose-response relationship was U-shaped, meaning more exercise is not linearly better.

   Liang Z, Wang C, Zhang X, et al. — Optimal modality and dose of exercise for relieving pain in patients with knee or hip osteoarthritis: Bayesian pairwise, network, and dose-response meta-analyses.. Seminars in Arthritis and Rheumatism, 2025. DOI: 10.1016/j.semarthrit.2025.152855.

3. OARSI's 2019 guideline is the only major osteoarthritis guideline that grades treatments separately for people with disease in MULTIPLE joints. Its Core Treatments for polyarticular OA are arthritis education and structured land-based exercise. Critically, intra-articular corticosteroid and intra-articular hyaluronic acid were Level 1B/2 options for knee OA only and were NOT recommended for hip or polyarticular OA; oral NSAIDs were not recommended at all for people with cardiovascular comorbidity or frailty; and paracetamol/acetaminophen was conditionally not recommended.

   Bannuru RR, Osani MC, Vaysbrot EE, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.. Osteoarthritis and Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

4. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programmes, tai chi, cane use, hand orthoses for first-CMC joint OA, tibiofemoral bracing, topical NSAIDs for the knee, oral NSAIDs and intra-articular glucocorticoid injections for the knee; acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol are only conditional.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020. DOI: 10.1002/art.41142.

5. The Cochrane review of land-based therapeutic exercise for knee osteoarthritis extracted data from 54 studies, with high-quality evidence from 44 trials (3,537 participants) that exercise reduces pain immediately after treatment, and further high-quality evidence that it improves physical function. Benefit attenuates but persists for at least two to six months after the programme ends.

   Fransen M, et al. — Exercise for osteoarthritis of the knee.. Cochrane Database Syst Rev, 2015. DOI: 10.1002/14651858.CD004376.pub3.

6. A 2025 Cochrane living review of 25 randomised trials (1,341 participants) found that compared with placebo injection, stem cell injections for knee osteoarthritis MAY slightly improve pain and function up to six months, on LOW-certainty evidence: mean pain was 4.5 of 10 with placebo and 1.2 points better with stem cells; function 46.3 of 100 with placebo and 14.2 points better. Certainty was downgraded for indirectness (source, preparation and dose of cells varied across studies) and suspected publication bias - up to three larger trials were conducted and then withdrawn before reporting. Radiographic progression was not assessed in ANY included study, and the review remains uncertain about harms.

   Whittle SL, Johnston RV, McDonald S, et al. — Stem cell injections for osteoarthritis of the knee.. Cochrane Database of Systematic Reviews, 2025. DOI: 10.1002/14651858.CD013342.pub2.

7. FDA states verbatim that of the products marketed as regenerative medicine - stem cell products, stromal vascular fraction from adipose tissue, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products - 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently no FDA-approved exosome products.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA (Center for Biologics Evaluation and Research), 2024.